» Articles » PMID: 16899215

SALL4 is Directly Activated by TCF/LEF in the Canonical Wnt Signaling Pathway

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2006 Aug 11
PMID 16899215
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

The SALL4 promoter has not yet been characterized. Animal studies showed that SALL4 is downstream of and interacts with TBX5 during limb and heart development, but a direct regulation of SALL4 by TBX5 has not been demonstrated. For other SAL genes, regulation within the Shh, Wnt, and Fgf pathways has been reported. Chicken csal1 expression can be activated by a combination of Fgf4 and Wnt3a or Wnt7a. Murine Sall1 enhances, but Xenopus Xsal2 represses, the canonical Wnt signaling. Here we describe the cloning and functional analysis of the SALL4 promoter. Within a minimal promoter region of 31bp, we identified a consensus TCF/LEF-binding site. The SALL4 promoter was strongly activated not only by LEF1 but also by TCF4E. Mutation of the TCF/LEF-binding site resulted in decreased promoter activation. Our results demonstrate for the first time the direct regulation of a SALL gene by the canonical Wnt signaling pathway.

Citing Articles

Sall4 regulates downstream patterning genes during limb regeneration.

Erickson J, Walker S, Arenas Gomez C, Echeverri K Dev Biol. 2024; 515:151-159.

PMID: 39067503 PMC: 11325254. DOI: 10.1016/j.ydbio.2024.07.015.


Immunotherapy, targeted therapy, and their cross talks in hepatocellular carcinoma.

Liu J, Park K, Shen Z, Lee H, Geetha P, Pakyari M Front Immunol. 2024; 14:1285370.

PMID: 38173713 PMC: 10762788. DOI: 10.3389/fimmu.2023.1285370.


The new advance of SALL4 in cancer: Function, regulation, and implication.

Abouelnazar F, Zhang X, Wang M, Zhang J, Yu D, Zang X J Clin Lab Anal. 2023; 37(9-10):e24927.

PMID: 37337914 PMC: 10388233. DOI: 10.1002/jcla.24927.


A natural transdifferentiation event involving mitosis is empowered by integrating signaling inputs with conserved plasticity factors.

Riva C, Hajduskova M, Gally C, Suman S, Ahier A, Jarriault S Cell Rep. 2022; 40(12):111365.

PMID: 36130499 PMC: 9513805. DOI: 10.1016/j.celrep.2022.111365.


SALL4: An Intriguing Therapeutic Target in Cancer Treatment.

Moein S, Tenen D, Amabile G, Chai L Cells. 2022; 11(16).

PMID: 36010677 PMC: 9406946. DOI: 10.3390/cells11162601.